The role of the insulin-like growth factor receptor, the insulin receptor substrate and PTEN in human prostate cancer progression

By Hellawell G.   Turner G.   Davies D.   Brewster S.   Macaulay V.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 33-33

Elsevier

Access to resources Recommend Favorite

Insulin-like growth factor I and prostate cancer

By O'Brien M.F.   Watson R.W.G.   Fitzpatrick J.M.  

Urology, Vol. 58, Iss. 1, 2001-07 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection

By Djavan B.   Bursa B.   Seitz C.   Soeregi G.   Remzi M.   Basharkhah A.   Wolfram R.   Marberger M.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 603-606

Elsevier

Access to resources Recommend Favorite

Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer

By Tricoli J.V.   Winter D.L.   Hanlon A.L.   Raysor S.L.   Watkins-Bruner D.   Pinover W.H.   Hanks G.E.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 178-182

Elsevier

Access to resources Recommend Favorite

Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men

By Sarma A.V.   Jaffe C.A.   Schottenfeld D.   Dunn R.   Montie J.E.   Cooney K.A.   Wei J.T.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 362-367

Elsevier

Access to resources Recommend Favorite